Pediatric rheumatic disease

Vaccination in pediatric rheumatic disease - Risks and benefits

Ginger Janow, Norman Todd Ilowite

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

In an age in which immunosuppression is the standard of care for many pediatric rheumatic diseases, balancing the risks and benefits of vaccinations is forefront. Three main issues-addressed in new guidelines-surround vaccination practices in these patients: safety, immunogenicity and effects of the vaccine on the underlying rheumatic disease.

Original languageEnglish (US)
Pages (from-to)188-190
Number of pages3
JournalNature Reviews Rheumatology
Volume8
Issue number4
DOIs
StatePublished - Apr 2012

Fingerprint

Rheumatic Diseases
Vaccination
Pediatrics
Standard of Care
Patient Safety
Immunosuppression
Guidelines
Vaccine Immunogenicity

ASJC Scopus subject areas

  • Rheumatology

Cite this

Pediatric rheumatic disease : Vaccination in pediatric rheumatic disease - Risks and benefits. / Janow, Ginger; Ilowite, Norman Todd.

In: Nature Reviews Rheumatology, Vol. 8, No. 4, 04.2012, p. 188-190.

Research output: Contribution to journalArticle

@article{19edecdda2fe4602be3c81b78a649e08,
title = "Pediatric rheumatic disease: Vaccination in pediatric rheumatic disease - Risks and benefits",
abstract = "In an age in which immunosuppression is the standard of care for many pediatric rheumatic diseases, balancing the risks and benefits of vaccinations is forefront. Three main issues-addressed in new guidelines-surround vaccination practices in these patients: safety, immunogenicity and effects of the vaccine on the underlying rheumatic disease.",
author = "Ginger Janow and Ilowite, {Norman Todd}",
year = "2012",
month = "4",
doi = "10.1038/nrrheum.2012.13",
language = "English (US)",
volume = "8",
pages = "188--190",
journal = "Nature reviews. Rheumatology",
issn = "1759-4790",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Pediatric rheumatic disease

T2 - Vaccination in pediatric rheumatic disease - Risks and benefits

AU - Janow, Ginger

AU - Ilowite, Norman Todd

PY - 2012/4

Y1 - 2012/4

N2 - In an age in which immunosuppression is the standard of care for many pediatric rheumatic diseases, balancing the risks and benefits of vaccinations is forefront. Three main issues-addressed in new guidelines-surround vaccination practices in these patients: safety, immunogenicity and effects of the vaccine on the underlying rheumatic disease.

AB - In an age in which immunosuppression is the standard of care for many pediatric rheumatic diseases, balancing the risks and benefits of vaccinations is forefront. Three main issues-addressed in new guidelines-surround vaccination practices in these patients: safety, immunogenicity and effects of the vaccine on the underlying rheumatic disease.

UR - http://www.scopus.com/inward/record.url?scp=84859442396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859442396&partnerID=8YFLogxK

U2 - 10.1038/nrrheum.2012.13

DO - 10.1038/nrrheum.2012.13

M3 - Article

VL - 8

SP - 188

EP - 190

JO - Nature reviews. Rheumatology

JF - Nature reviews. Rheumatology

SN - 1759-4790

IS - 4

ER -